Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women

Completed · Phase 2/Phase 3

Conditions studied: Non-anemic Iron Deficiency

In brief

Healthy premenopausal women that are iron-deficient without anemia will receive a low-dose iron dietary supplement. The investigators seek to determine if the low-dose iron dietary supplement will restore iron levels to normal range with fewer side effects than typically experienced at higher doses of iron supplementation.

Key facts

Study ID

NCT02683369

Run by

University of Maryland, Baltimore

People needed

23

Starts

2016-02-01

Expected to finish

2017-05-01

Last updated by the study team

2019-08-16

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pre-menopausal
• Iron deficient without anemia (serum ferritin concentration < 20 ug/L and a hemoglobin concentration > 120 g/L)
• Agree to continue with current diet and any dietary supplements
• Able to understand and write English
• Voluntarily consent to the study and understand its nature and purpose including potential risks and side effects

You may not qualify if…

• Daily supplementation of another iron supplement (other than multivitamin) currently or within past 2 weeks
• Pregnant or breastfeeding females
• History of alcohol, drug, or medication abuse
• Known allergies to any substance in the study product
• Donated blood in the past month or plan to do so at any time during the 8-week trial
• Current diagnosis of inflammatory bowel disease (Crohn's or Ulcerative Colitis)
• Taking medication that my interfere with the absorption of iron
• Current tobacco smoker

Where it is running

• Center for Integrative Medicine University of Maryland — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.